These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20713835)

  • 1. Actinic keratosis on a continuum with squamous cell carcinoma.
    Hurwitz RM; Buckel LJ
    Arch Dermatol; 2010 Aug; 146(8):923-4. PubMed ID: 20713835
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
    Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
    Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous-cell carcinoma in situ is a fiction!
    Ackerman AB; Mones J
    J Cutan Pathol; 2009 Jan; 36(1):74-5; author reply 76. PubMed ID: 19125737
    [No Abstract]   [Full Text] [Related]  

  • 4. Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization?
    Deltondo JA; Helm KF
    G Ital Dermatol Venereol; 2009 Aug; 144(4):441-4. PubMed ID: 19755947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma.
    Toll A; Salgado R; Yébenes M; Martín-Ezquerra G; Gilaberte M; Baró T; Solé F; Alameda F; Espinet B; Pujol RM
    Br J Dermatol; 2009 Nov; 161(5):1112-8. PubMed ID: 19673870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of actinic keratoses and early squamous cell carcinoma.
    Wheller L; Soyer HP
    Curr Probl Dermatol; 2015; 46():58-63. PubMed ID: 25561207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haptoglobin polymorphism and the risk of actinic keratoses and cutaneous squamous cell carcinoma: A case-control study.
    Brochez L; Speeckaert R; De Bacquer D; Delanghe J; Hoorens I
    J Dermatol; 2019 Mar; 46(3):274-275. PubMed ID: 30614562
    [No Abstract]   [Full Text] [Related]  

  • 8. Actinic keratosis is squamous cell carcinoma.
    Lober BA; Lober CW
    South Med J; 2000 Jul; 93(7):650-5. PubMed ID: 10923948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actinic keratosis: do the numbers add up?
    Stanger CB
    Nurse Pract; 2009 Feb; 34(2):36-9. PubMed ID: 19155885
    [No Abstract]   [Full Text] [Related]  

  • 11. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes.
    Anwar J; Wrone DA; Kimyai-Asadi A; Alam M
    Clin Dermatol; 2004; 22(3):189-96. PubMed ID: 15262304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New dermoscopic pattern in actinic keratosis and related conditions.
    Cuellar F; Vilalta A; Puig S; Palou J; Salerni G; Malvehy J
    Arch Dermatol; 2009 Jun; 145(6):732. PubMed ID: 19528439
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging drugs for actinic keratosis.
    Ulrich M; Drecoll U; Stockfleth E
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What lies beneath actinic keratosis? Looking beyond visible lesions to optimize patient outcomes.
    Lear JT
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():3-4. PubMed ID: 28263019
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
    Hodges A; Smoller BR
    Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence diagnosis in actinic keratosis and squamous cell carcinoma.
    Kleinpenning MM; Wolberink EW; Smits T; Blokx WA; van De Kerkhof PC; van Erp PE; Gerritsen RM
    Photodermatol Photoimmunol Photomed; 2010 Dec; 26(6):297-302. PubMed ID: 21091787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From actinic keratosis to squamous cell carcinoma: evidence of morphologic and biologic progression.
    Ruini C; Witkowski AM; Cesinaro A; Teixeira De Carvalho N; Pellacani G
    J Am Acad Dermatol; 2015 Jan; 72(1 Suppl):S8-S10. PubMed ID: 25500054
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
    Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
    Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.